reglab/housing_qa huggingface dataset:
IN Code § 16-41-6-11 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 6. Communicable Disease: Mandatory Testing of Individuals With Communicable or Serious Diseases|16-41-6-11. Rules

Sec. 11. (a) The state department shall adopt rules under IC 4-22-2 that include procedures:(1) to inform the woman of the test results under this chapter, whether they are positive or negative;(2) for explaining the side effects of any treatment for HIV if the test results under this chapter are positive; and(3) to establish a process for a woman who tests positive under this chapter to appeal the woman's status on a waiting list on a treatment program for which the woman is eligible. The rule must:(A) include a requirement that the state department make a determination in the process described in this subdivision not later than seventy-two (72) hours after the state department receives all the requested medical information; and(B) set forth the necessary medical information that must be provided to the state department and reviewed by the state department in the process described in this subdivision.(b) The state department shall maintain rules under IC 4-22-2 that set forth standards to provide to women who are pregnant, before delivery, at delivery, and after delivery, information concerning HIV. The rules must include:(1) an explanation of the nature of AIDS and HIV;(2) information concerning discrimination and legal protections;(3) information concerning the duty to notify persons at risk as described in IC 16-41-7-1;(4) information about risk behaviors for HIV transmission;(5) information about the risk of transmission through breast feeding;(6) notification that if the woman chooses not to be tested for HIV before delivery, at delivery the child will be tested subject to section 4 of this chapter;(7) procedures for obtaining informed, written consent for testing under this chapter;(8) procedures for post-test counseling by a health care provider when the test results are communicated to the woman, whether the results are positive or negative;(9) procedures for referral for physical and emotional services if the test results are positive;(10) procedures for explaining the importance of immediate entry into medical care if the test results are positive; and(11) procedures for explaining that the use of antiretroviral drugs and other medical interventions lessen the likelihood of transmitting HIV to the child during childbirth.As added by P.L.237-2003, SEC.14. Amended by P.L.112-2020, SEC.21.
IN Code § 16-41-6-12 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 6. Communicable Disease: Mandatory Testing of Individuals With Communicable or Serious Diseases|16-41-6-12. Completing HIV Test History and Assessment Form; Retaining Copy of Form in Patient's Medical File; Systemwide Evaluation of Prenatal HIV Testing

Sec. 12. (a) The state department shall provide that an HIV test history and assessment form from the patient's medical records or an interview with the patient must be filled out. The state department shall develop the form to determine if:(1) the patient is HIV positive and has been informed; or(2) the patient was tested during the current pregnancy and tested negative or was not tested during the current pregnancy and the HIV status is unknown.(b) The form required under subsection (a) must identify what special support or assistance for continued medical care the patient might need as a result of a positive test.(c) A copy of the form must be:(1) kept in the patient's medical file;(2) kept in the baby's medical file; and(3) given to the doctor in the hospital designated to administer the newborn HIV testing program.(d) The state department must maintain a systemwide evaluation of prenatal HIV testing in Indiana. The state department shall prescribe the HIV test history and assessment form and a newborn blood screening form. The state department shall remove all identifying information from the maternal test history before the state department performs its analyses and shall not maintain HIV test history data with identifying information.As added by P.L.237-2003, SEC.15.
IN Code § 16-41-6-13 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 6. Communicable Disease: Mandatory Testing of Individuals With Communicable or Serious Diseases|16-41-6-13. Treatment Program Access for Women Who Test Positive for HIV

Sec. 13. (a) Women who:(1) meet all qualifications to participate in the children's health insurance program, the AIDS drug assistance program, the health insurance assistance program, or any other health care program of the state; and(2) test positive under section 5 or 6 of this chapter;shall be given first priority on a waiting list for the program if a waiting list exists. If a program does not have a waiting list, the woman described in this subsection shall be automatically approved and accepted into the program.(b) If the state department determines during the process described in section 11(a)(3) of this chapter that the treatment of a woman who tests positive under this chapter should not be interrupted because of medical necessity, the woman may enter a program described in subsection (a) regardless of the existence of a waiting list for the program.As added by P.L.237-2003, SEC.16.
IN Code § 16-41-7-1 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7. Communicable Disease: Duty or Authority to Inform or Notify|16-41-7-1. Individual With a Communicable Disease's Duty to Inform Persons at Risk

Sec. 1. (a) This section applies to the following serious communicable diseases:(1) Human immunodeficiency virus (HIV).(2) Hepatitis B.(b) As used in this section, "high risk activity" means sexual or needle sharing contact that has been epidemiologically demonstrated, as determined by the federal Centers for Disease Control and Prevention, to bear a significant risk of transmitting a serious communicable disease described in subsection (a).(c) As used in this section, "person at risk" means:(1) past and present sexual or needle sharing partners who may have engaged in high risk activity; or(2) sexual or needle sharing partners before engaging in high risk activity;with an individual with a communicable disease who has a serious communicable disease described in subsection (a).(d) Individuals with a communicable disease who know of their status as an individual with a communicable disease and have a serious communicable disease described in subsection (a) have a duty to inform or cause to be notified by a third party a person at risk of the following:(1) The individual with a communicable disease's disease status.(2) The need to seek health care such as counseling and testing.[Pre-1993 Recodification Citation: 16-1-10.5-8.5.]As added by P.L.2-1993, SEC.24. Amended by P.L.112-2020, SEC.22.
IN Code § 16-41-7-2 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7. Communicable Disease: Duty or Authority to Inform or Notify|16-41-7-2. Reporting of Persons Posing a Serious and Present Risk or Being at Risk

Sec. 2. (a) An individual with a communicable disease is a "serious and present risk to the health of others" under the following conditions:(1) The individual with a communicable disease engages repeatedly in a behavior that has been demonstrated epidemiologically (as defined by rules adopted by the state department under IC 4-22-2) to transmit a serious communicable disease or that indicates a careless disregard for the transmission of the disease to others.(2) The individual with a communicable disease's past behavior or statements indicate an imminent risk that the individual with a communicable disease will engage in behavior that transmits a serious communicable disease to others.(3) The individual with a communicable disease has failed or refused to carry out the individual with a communicable disease's duty to inform under section 1 of this chapter.(b) A person who has reasonable cause to believe that a person:(1) is a serious and present risk to the health of others as described in subsection (a);(2) has engaged in noncompliant behavior; or(3) is suspected of being a person at risk (as described in section 1 of this chapter);may report that information to a health officer.(c) A person who makes a report under subsection (b) in good faith is not subject to liability in a civil, an administrative, a disciplinary, or a criminal action.(d) A person who knowingly or recklessly makes a false report under subsection (b) is civilly liable for actual damages suffered by a person reported on and for punitive damages.[Pre-1993 Recodification Citations: 16-1-10.5-9; 16-1-10.5-11.]As added by P.L.2-1993, SEC.24. Amended by P.L.112-2020, SEC.23.
IN Code § 16-41-7-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7. Communicable Disease: Duty or Authority to Inform or Notify|16-41-7-3. Notification by Physician

Sec. 3. (a) A licensed physician who diagnoses, treats, or counsels a patient with a serious communicable disease shall inform the patient of the patient's duty under section 1 of this chapter.(b) A physician described in subsection (a) may notify the following:(1) A health officer if the physician has reasonable cause to believe that a patient:(A) is a serious and present risk to the health of others as described in section 2(a) of this chapter;(B) has engaged in noncompliant behavior; or(C) is suspected of being a person at risk (as defined in section 1 of this chapter).(2) A person at risk (as defined in section 1 of this chapter) or a person legally responsible for the patient if the physician:(A) has medical verification that the patient is an individual with a communicable disease;(B) knows the identity of the person at risk;(C) has a reasonable belief of a significant risk of harm to the identified person at risk;(D) has reason to believe the identified person at risk has not been informed and will not be informed of the risk by the patient or another person; and(E) has made reasonable efforts to inform the individual with a communicable disease of the physician's intent to make or cause the state department of health to make a disclosure to the person at risk.(c) A physician who notifies a person at risk under this section shall do the following:(1) Identify the serious communicable disease.(2) Inform the person of available health care measures such as counseling and testing.(d) A physician who in good faith provides notification under this section is not subject to liability in a civil, an administrative, a disciplinary, or a criminal action.(e) A patient's privilege with respect to a physician under IC 34-46-3-1 is waived regarding:(1) notification under subsection (b); and(2) information provided about a patient's noncompliant behavior in an investigation or action under this chapter, IC 16-41-2, IC 16-41-3, IC 16-41-5, IC 16-41-6, IC 16-41-8, IC 16-41-9, IC 16-41-13, IC 16-41-14, and IC 16-41-16.(f) A physician's immunity from liability under subsection (d) applies only to the provision of information reasonably calculated to protect an identified person who is at epidemiological risk of infection.(g) A physician who notifies a person under this section is also required to satisfy the reporting requirements under IC 16-41-2-2 through IC 16-41-2-8.[Pre-1993 Recodification Citation: 16-1-10.5-11.5.]As added by P.L.2-1993, SEC.24. Amended by P.L.1-1998, SEC.122; P.L.112-2020, SEC.24.
IN Code § 16-41-7-4 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7. Communicable Disease: Duty or Authority to Inform or Notify|16-41-7-4. Investigation of Persons With a Communicable Disease; Notification of Persons at Risk

Sec. 4. (a) As used in this section, "person at risk" means an individual who in the best judgment of a licensed physician:(1) has engaged in high risk activity (as defined in section 1 of this chapter); or(2) is in imminent risk of engaging in high risk activity (as defined in section 1 of this chapter).(b) If a health officer is notified in writing by a physician under section 3(b)(1)(A) of this chapter of a patient:(1) for whom the physician has medical verification that the patient is an individual with a communicable disease; and(2) who, in the best judgment of the physician, is a serious and present risk to the health of others;the health officer shall make an investigation of the individual with a communicable disease as authorized in IC 16-41-5-2 to determine whether the environmental conditions surrounding the individual with a communicable disease or the conduct of the individual with a communicable disease requires the intervention by the health officer or designated health official to prevent the transmission of disease to others.(c) If the state department is requested in writing by a physician who has complied with the requirements of section 3(b)(2) of this chapter to notify a person at risk, the state department shall notify the person at risk unless, in the opinion of the state department, the person at risk:(1) has already been notified;(2) will be notified; or(3) will otherwise be made aware that the person is a person at risk.(d) The state department shall establish a confidential registry of all persons submitting written requests under subsection (c).(e) The state department shall adopt rules under IC 4-22-2 to implement this section. Local health officers may submit advisory guidelines to the state department to implement this chapter, IC 16-41-1, IC 16-41-3, IC 16-41-5, IC 16-41-8, or IC 16-41-9. The state department shall fully consider such advisory guidelines before adopting a rule under IC 4-22-2-29 implementing this chapter, IC 16-41-1, IC 16-41-3, IC 16-41-5, IC 16-41-8, or IC 16-41-9.[Pre-1993 Recodification Citation: 16-1-10.5-11.6.]As added by P.L.2-1993, SEC.24. Amended by P.L.112-2020, SEC.25.
IN Code § 16-41-7-5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7. Communicable Disease: Duty or Authority to Inform or Notify|16-41-7-5. Violations

Sec. 5. (a) Except as provided in IC 35-45-21-3, a person who recklessly violates or fails to comply with this chapter commits a Class B misdemeanor.(b) Each day a violation continues constitutes a separate offense.[Pre-1993 Recodification Citation: 16-1-35-1.]As added by P.L.2-1993, SEC.24. Amended by P.L.1-1999, SEC.47; P.L.158-2013, SEC.240.
IN Code § 16-41-7.5-1 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-1. "Local Health Department"

Sec. 1. As used in this chapter, "local health department" refers to:(1) a local health department established under IC 16-20; or(2) the health and hospital corporation created under IC 16-22-8.As added by P.L.208-2015, SEC.9.
IN Code § 16-41-7.5-2 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-2. "Program"

Sec. 2. As used in this chapter, "program" means a syringe exchange program operated under this chapter.As added by P.L.208-2015, SEC.9.
IN Code § 16-41-7.5-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-3. "Qualified Entity"

Sec. 3. As used in this chapter, "qualified entity" means any of the following:(1) A local health department.(2) A municipality (as defined by IC 36-1-2-11) that operates a program within the boundaries of the municipality.(3) A nonprofit organization that operates a program and has been approved by official action to operate the program by:(A) the local health department;(B) the executive body of the county; or(C) the legislative body of a municipality for the operation of a program within the boundaries of the municipality.As added by P.L.208-2015, SEC.9.
IN Code § 16-41-7.5-4 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-4. Location of Programs; Complying With Requirements

Sec. 4. (a) A qualified entity may operate a program only in a county or municipality where:(1) a public health emergency has been declared; or(2) a program has been approved;under section 5 of this chapter. However, a qualified entity may not operate a program outside of the jurisdictional area of the governmental body that approved the qualified entity.(b) A qualified entity that meets the requirements in subsection (a) and complies with the requirements of this chapter may operate a program.As added by P.L.208-2015, SEC.9. Amended by P.L.198-2017, SEC.1.
IN Code § 16-41-7.5-5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-5. Requirements to Operate a Program

Sec. 5. Before a qualified entity may operate a program in a county, the following shall occur:(1) The local health officer or the executive director must declare to the executive body of the county or the legislative body of the municipality the following:(A) There is an epidemic of hepatitis C or HIV.(B) That the primary mode of transmission of hepatitis C or HIV in the county is through intravenous drug use.(C) That a syringe exchange program is medically appropriate as part of a comprehensive public health response.(2) The legislative body of the municipality or the executive body of the county must do the following:(A) Conduct a public hearing that allows for public testimony.(B) Take official action adopting the declarations under subdivision (1) by the local health officer or the executive director in consideration of the public health for the area and, if the program complies with section 6 of this chapter and is within the jurisdictional limits of the county or municipality that the body represents, either:(i) approve the operation of the program; or(ii) submit a request under subdivision (3) to the state health commissioner.(3) The legislative body of the municipality or the executive body of the county that took official action under subdivision (2) either:(A) notifies the state health commissioner of the body's actions under subdivision (2), including:(i) the period of time considered medically appropriate for the program;(ii) whether a renewal or an extension of the program can occur; and(iii) other measures taken concerning the epidemic that have proven ineffective; or(B) if the body does not approve the operation of a program under subdivision (2)(B)(i) and submits a request under subdivision (2)(B)(ii), request that the state health commissioner declare a public health emergency and approve the operation of a program.(4) If subdivision (3)(B) applies, the state health commissioner has declared a public health emergency for the county or municipality and approved the operation of a program.As added by P.L.208-2015, SEC.9. Amended by P.L.198-2017, SEC.2.
IN Code § 16-41-7.5-6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-6. Duties

Sec. 6. A qualified entity that operates a program under this chapter must do the following:(1) Annually register the program in a manner prescribed by the state department with the:(A) state department; and(B) local health department in the county or municipality where services will be provided by the qualified entity if the qualified entity is not the local health department.(2) Have one (1) of the following licensed in Indiana provide oversight to the qualified entity's programs:(A) A physician.(B) A registered nurse.(C) A physician assistant.(3) Store and dispose of all syringes and needles collected in a safe and legal manner.(4) Provide education and training on drug overdose response and treatment, including the administration of an overdose intervention drug.(5) Provide drug addiction treatment information and referrals to drug treatment programs, including programs in the local area and programs that offer medication assisted treatment that includes a federal Food and Drug Administration approved long acting, nonaddictive medication for the treatment of opioid or alcohol dependence.(6) Provide syringe and needle distribution and collection without collecting or recording personally identifiable information.(7) Operate in a manner consistent with public health and safety.(8) Ensure the program is medically appropriate and part of a comprehensive public health response.(9) Keep sufficient quantities of an overdose intervention drug (as defined in IC 16-18-2-263.9) in stock and to administer in accordance with IC 16-42-27.(10) Provide testing for communicable diseases, and if an individual tests positive for a communicable disease, provide health care services or a referral to a health care provider for the services.(11) Establish a referral process for program participants in need of:(A) information or education concerning communicable diseases; or(B) health care.As added by P.L.208-2015, SEC.9. Amended by P.L.198-2017, SEC.3; P.L.112-2020, SEC.26.
IN Code § 16-41-7.5-7 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-7. Termination

Sec. 7. (a) The following may terminate the approval of a qualified entity:(1) The legislative body of the municipality, the executive body of the county, or the local health department that approved the qualified entity.(2) The state health commissioner, if the state health commissioner determines that the qualified entity has failed to comply with section 6 of this chapter.(b) If a person described in subsection (a)(1) or (a)(2) terminates the approval of a qualified entity, the person shall notify the other person with authority to terminate that is described in subsection (a) of the termination.As added by P.L.208-2015, SEC.9.
IN Code § 16-41-7.5-8 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-8. Use of State Funds

Sec. 8. A state agency may not provide funds to a qualified entity to purchase or otherwise acquire hypodermic syringes or needles for a program under this chapter.As added by P.L.208-2015, SEC.9.
IN Code § 16-41-7.5-9 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 7.5. Communicable Disease: Syringe Exchange Program|16-41-7.5-9. Attending a Program Does Not Constitute Reasonable Suspicion or Probable Cause

Sec. 9. (a) A law enforcement officer may not stop, search, or seize an individual based on the fact the individual has attended a program under this chapter.(b) The fact an individual has attended a program under this chapter may not be the basis, in whole or in part, for a determination of probable cause or reasonable suspicion by a law enforcement officer.As added by P.L.208-2015, SEC.9. Amended by P.L.44-2016, SEC.1.